Study IDs new type 2 diabetes marker

11/7/2012 | Medical News Today

People who have above-average levels of SFRP4 protein in their blood have a higher risk of developing type 2 diabetes compared with those with below-average levels, research published in Cell Metabolism found. The findings suggest SFRP4, which has a part in inflammatory processes, may serve as a marker for diabetes risk and may lead to the development of new diabetes treatments, researchers said.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA